mitochondrial DNA

Overview

Mitochondrial DNA (mtDNA) is the small, circular genome located within mitochondria, the organelles responsible for oxidative phosphorylation and cellular energy production. In humans, mtDNA encodes a limited set of genes essential for respiratory chain function, while the majority of mitochondrial proteins are encoded by nuclear DNA and imported into the organelle. Because mtDNA is present in multiple copies per cell and is closely tied to mitochondrial metabolism, its integrity, copy number, and inheritance pattern are biologically important for normal cellular function.

Clinically, mtDNA is relevant to a wide range of diseases because mutations, depletion, damage, or abnormal release of mtDNA can impair energy metabolism and also act as a danger signal. When mtDNA escapes from mitochondria into the cytoplasm or extracellular space, it can activate innate immune pathways such as cGAS-STING and, in some settings, the NLRP3 inflammasome, contributing to inflammation. mtDNA variation is also widely used in population genetics and haplogroup analysis, and it remains a major target in mitochondrial disease research, neurodegeneration, cardiometabolic disease, cancer biology, and diagnostic assay development.

Focus of Latest Publications

Recent investigations have established mitochondrial DNA (mtDNA) as a critical danger-associated molecular pattern that triggers innate immune responses across diverse pathological contexts. Multiple studies demonstrate that mtDNA release from mitochondria activates the cGAS-STING signaling pathway, a central node in innate immunity. Research has characterized distinct mechanisms enabling this release: oxidative stress promotes voltage-dependent anion channel 1 (VDAC1)-mediated leakage in fibroblasts; radiation and genotoxic stress induce senescence-associated mtDNA discharge; and cuproptosis-driven mitochondrial collapse causes mtDNA efflux. Once released, cytosolic mtDNA potently activates cGAS-STING and related inflammasome pathways, driving proinflammatory cytokine production and immune cell activation.

Recognizing mtDNA release as a pathological driver, several therapeutic strategies focus on suppressing its leakage to attenuate disease progression. In radiation-induced pulmonary fibrosis, emodin preserved mitochondrial integrity and prevented mtDNA cytoplasmic accumulation, thereby blocking senescence-associated inflammation and fibrosis. Similarly, metformin inhibited mtDNA release in Huntington's disease, reducing microglial activation and neuroinflammation in affected brain regions. In vitiligo, pharmacological inhibition of VDAC1 oligomerization prevented mtDNA leakage from dermal fibroblasts, attenuating the cGAS-STING-driven inflammatory cascade that drives melanocyte destruction.

Conversely, recent cancer immunotherapy approaches deliberately harness mtDNA release as an immune-activating mechanism. Copper nanoassemblies engineered with tumor-targeting peptides trigger cuproptosis-mediated mitochondrial collapse and mtDNA release in cervical cancer cells, activating cGAS-STING-interferon regulatory factor 3 signaling and reshaping the antitumor immune microenvironment. Similarly, programmable DNAzyme nanocatalysts induce sustained reactive oxygen species accumulation and mitochondrial dysfunction, leading to mtDNA cytosolic accumulation and cGAS-STING activation; this transient immune sensitization window enhances dendritic cell maturation and cytotoxic T cell infiltration when combined with checkpoint inhibitors.

Beyond direct mitochondrial dynamics, mtDNA serves as a cargo molecule in extracellular vesicles, mediating intercellular communication with systemic consequences. Lipid-overloaded Sertoli cells release extracellular vesicles enriched in mtDNA, which, when taken up by spermatogonia, induce oxidative stress and reprogramming of germ cell metabolism. Paternally inherited mtDNA-containing vesicles subsequently predispose offspring to developmental retardation and heightened susceptibility to metabolic disease, including hepatic lipid accumulation, highlighting mtDNA's dual role as both a local inflammatory trigger and a systemically transmitted signal governing metabolic and immune homeostasis.